This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on Web of Science (1)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Comparative Effects on Growth and Spread of Mouse Lewis Lung Cancer

John A. Greager, MD; Gregory Culberson, MD; Bradley Manning, MD; T. K. Das Gupta, MD, PhD

Arch Surg. 1975;110(8):901-902.

Abstract
In 101 mice, Lewis lung tumor (25 mg apiece) was implanted subcutaneously in the right hind limb and the mice separated into various groups and protocols to test treatment with immunotherapeutic and chemotherapeutic agents. In those treated intralesionally with BCG, the growth of primary tumor was retarded (P .05). Tumor growth in animals treated with systemic BCG and serum from tumor-bearing mice was not different from controls. In 14 of 20 mice treated with chemotherapy (semustine and cyclophosphamide), there was no primary or metastatic growth (P .01). The observations show that this sort of systemic immunotherapy had no effect on mouse Lewis lung tumor, that intralesionally there was a retarding effect of BCG (although it did not influence metastases), and that this protocol of chemotherapy was strikingly effective.

Author Affiliations
From the Division of Surgical Oncology, Abraham Lincoln School of Medicine, University of Illinois College of Medicine, Chicago.

Footnotes
Accepted for publication March 14, 1975.

Read before the 32nd annual meeting of the Central Surgical Association, Chicago, Feb 27, 1975.

Reprint requests to Division of Surgical Oncology, Abraham Lincoln School of Medicine, University of Illinois College of Medicine, 840 S Wood St, Chicago, IL 60612 (Dr. Greager).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?